CXCR3-activating peptide inhibits pulmonary fibrosis in a bleomycin mouse model
Abstract Abnormal wound healing and dysregulated inflammation in the lung results in scarring and progressive fibrosis, which are hallmarks of Idiopathic Pulmonary Fibrosis (IPF) and post-COVID injury-related lung fibrosis. Chemokine signaling through the CXCR3 receptor and the CXCR3-activating chem...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2025-10-01
|
| Sarja: | Respiratory Research |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s12931-025-03384-6 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|